2Roden DM.Current status of class Ⅲ antiarrhythmic drug therapy[J].Am J Cardiol,1993,72:44-44.
3[1]Burkart F, Pfisterer M, Kiowski W, et al. Effect of antiarrhythmic therapy on mortality in sutrvivors of myocardial infarction with asymptomatic com plex ventricutlar arrhythmias: basel antiarrhythmic study of infarct survival (BASIS)[J].J Am Coll Cardiol, 1990,16:1711
4[2]Cairns JA, Connolly SJ, Roberts RS, et al. Canadian Amiodarone Myocar dial Infarction Arrhythmia Trial Investigators. Randomized trial of out come after myocardial infarction in patients with frequent or repetitive ventricular premature depolarization: CAMIT[ J]. Lancet 1999,353: 9
5[3]Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in conges tive heart failure: meta-analysis of individual data from 6500 patients in randomised trials[ J]. Lancet, 1997,350:1417
6[4]Kudenchuk PJ,Cobb LA,Copass MK,et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation[J]. N Engl J Med, 1999,341:871
7[5]Frams LH. The effect of chronic oral and acute intravenons amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs[ J ]. PACE, 1989,12: 339
8[6]Schmidt A, Konig W, Binner L, et al. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias[ J]. Clin Cardiol, 1988,11:481
9[7]David L. Intravenous amiodarone in the treatment of refractory life threatening cardiac arrhythmias in the critically ill patient[J]. Am Heart J, 1986,111:456
10[8]Scheinman MM, Levine JH, Cannom DS, et al. Dose-Ranging study of in travenous amiodarone in patients with life-threatening ventricular tach yarrhythmias[ J]. Circulation, 1995,92: 3264
